ZA97364B - Quinolin-2-(1h)-ones - Google Patents
Quinolin-2-(1h)-onesInfo
- Publication number
- ZA97364B ZA97364B ZA97364A ZA97364A ZA97364B ZA 97364 B ZA97364 B ZA 97364B ZA 97364 A ZA97364 A ZA 97364A ZA 97364 A ZA97364 A ZA 97364A ZA 97364 B ZA97364 B ZA 97364B
- Authority
- ZA
- South Africa
- Prior art keywords
- quinolin
- ones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19601782A DE19601782A1 (de) | 1996-01-19 | 1996-01-19 | Chinolin-2-(1H)one |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA97364B true ZA97364B (en) | 1997-07-22 |
Family
ID=7783141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA97364A ZA97364B (en) | 1996-01-19 | 1997-01-16 | Quinolin-2-(1h)-ones |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6028080A (fr) |
| EP (1) | EP0885196A1 (fr) |
| JP (1) | JP2000503308A (fr) |
| KR (1) | KR19990077308A (fr) |
| CN (1) | CN1211974A (fr) |
| AR (1) | AR005646A1 (fr) |
| AU (1) | AU716230B2 (fr) |
| BR (1) | BR9707027A (fr) |
| CA (1) | CA2243474C (fr) |
| CZ (1) | CZ224098A3 (fr) |
| DE (1) | DE19601782A1 (fr) |
| HU (1) | HUP9900563A3 (fr) |
| MX (1) | MX9805700A (fr) |
| NO (1) | NO983333L (fr) |
| PL (1) | PL327829A1 (fr) |
| SK (1) | SK93198A3 (fr) |
| WO (1) | WO1997026244A1 (fr) |
| ZA (1) | ZA97364B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02004330A (es) * | 1999-11-03 | 2004-07-30 | Albany Molecular Res Inc | Tetrahidroisoquinolinas aril-y heteroaril-sustituidas y uso de las mismas para bloquear la recaptacion de norepinefrina, dopamina y serotonina.. |
| US7273889B2 (en) * | 2002-09-25 | 2007-09-25 | Innovative Drug Delivery Systems, Inc. | NMDA receptor antagonist formulation with reduced neurotoxicity |
| US7166738B2 (en) * | 2004-04-23 | 2007-01-23 | Roche Palo Alto Llc | Non-nucleoside reverse transcriptase inhibitors |
| US7625949B2 (en) * | 2004-04-23 | 2009-12-01 | Roche Palo Alto Llc | Methods for treating retroviral infections |
| WO2007045573A1 (fr) * | 2005-10-19 | 2007-04-26 | F. Hoffmann-La Roche Ag | Phénylacétamides en tant qu'inhibiteurs de nnrt |
| US8242145B2 (en) * | 2008-02-14 | 2012-08-14 | Panmira Pharmaceuticals, Llc | Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors |
| WO2009108720A2 (fr) | 2008-02-25 | 2009-09-03 | Amira Pharmaceuticals, Inc. | Antagonistes des récepteurs d2 de la prostaglandine |
| US8415479B2 (en) | 2008-03-31 | 2013-04-09 | Renascience Co., Ltd. | Inhibitor of plasminogen activator inhibitor-1 |
| EP2268611A2 (fr) * | 2008-04-02 | 2011-01-05 | Amira Pharmaceuticals, Inc. | Antagonistes d aminoalkylphényle de récepteurs de prostaglandine d<sb>2</sb> |
| GB2463788B (en) * | 2008-09-29 | 2010-12-15 | Amira Pharmaceuticals Inc | Heteroaryl antagonists of prostaglandin D2 receptors |
| US8378107B2 (en) | 2008-10-01 | 2013-02-19 | Panmira Pharmaceuticals, Llc | Heteroaryl antagonists of prostaglandin D2 receptors |
| WO2010057118A2 (fr) | 2008-11-17 | 2010-05-20 | Amira Pharmaceuticals, Inc. | Antagonistes hétérocycliques des récepteurs de la prostaglandine d2 |
| WO2010113022A1 (fr) | 2009-03-31 | 2010-10-07 | 株式会社レナサイエンス | Agent inhibiteur de l'inhibiteur de l'activateur du plasminogène 1 |
| KR20120115989A (ko) | 2010-01-06 | 2012-10-19 | 판미라 파마슈티칼스, 엘엘씨 | Ｄｐ2 길항제 및 이의 용도 |
| US10092537B2 (en) | 2013-04-15 | 2018-10-09 | Renascience Co., Ltd. | Use for PAI-1 inhibitor |
| CA3164022A1 (fr) | 2020-01-22 | 2021-07-29 | Raj Mehra | Reduction des effets secondaires d'antagonistes de nmda |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5268378A (en) * | 1990-05-31 | 1993-12-07 | Merck Sharp & Dohme, Limited | Dioxo-tetrahydroquinoline derivatives |
| DE69113115T2 (de) * | 1990-05-31 | 1996-06-13 | Merck Sharp & Dohme | Dioxo-tetrahydrochinolinderivate. |
| GB9022785D0 (en) * | 1990-10-19 | 1990-12-05 | Merck Sharp & Dohme | Therapeutic agents |
| GB9125515D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
| EP0685466A1 (fr) * | 1994-06-02 | 1995-12-06 | Ciba-Geigy Ag | Dérivés de 3-hétéroaliphatyle- et 3-(hétéro)-(aryle)-aliphatyle-2(1H)-quinolone |
-
1996
- 1996-01-19 DE DE19601782A patent/DE19601782A1/de not_active Withdrawn
-
1997
- 1997-01-10 KR KR1019980705454A patent/KR19990077308A/ko not_active Withdrawn
- 1997-01-10 AU AU13112/97A patent/AU716230B2/en not_active Ceased
- 1997-01-10 WO PCT/EP1997/000084 patent/WO1997026244A1/fr not_active Ceased
- 1997-01-10 EP EP97900586A patent/EP0885196A1/fr not_active Withdrawn
- 1997-01-10 JP JP9525656A patent/JP2000503308A/ja not_active Withdrawn
- 1997-01-10 BR BR9707027A patent/BR9707027A/pt unknown
- 1997-01-10 CN CN97192395A patent/CN1211974A/zh active Pending
- 1997-01-10 CA CA002243474A patent/CA2243474C/fr not_active Expired - Fee Related
- 1997-01-10 PL PL97327829A patent/PL327829A1/xx unknown
- 1997-01-10 CZ CZ982240A patent/CZ224098A3/cs unknown
- 1997-01-10 SK SK931-98A patent/SK93198A3/sk unknown
- 1997-01-10 US US09/101,837 patent/US6028080A/en not_active Expired - Fee Related
- 1997-01-10 HU HU9900563A patent/HUP9900563A3/hu unknown
- 1997-01-16 ZA ZA97364A patent/ZA97364B/xx unknown
- 1997-01-17 AR ARP970100184A patent/AR005646A1/es unknown
-
1998
- 1998-07-15 MX MX9805700A patent/MX9805700A/es unknown
- 1998-07-17 NO NO983333A patent/NO983333L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9900563A2 (hu) | 1999-06-28 |
| CZ224098A3 (cs) | 1998-10-14 |
| MX9805700A (es) | 1998-11-29 |
| US6028080A (en) | 2000-02-22 |
| AU716230B2 (en) | 2000-02-24 |
| EP0885196A1 (fr) | 1998-12-23 |
| HUP9900563A3 (en) | 2000-02-28 |
| PL327829A1 (en) | 1999-01-04 |
| AR005646A1 (es) | 1999-07-14 |
| JP2000503308A (ja) | 2000-03-21 |
| KR19990077308A (ko) | 1999-10-25 |
| DE19601782A1 (de) | 1997-07-24 |
| CN1211974A (zh) | 1999-03-24 |
| AU1311297A (en) | 1997-08-11 |
| CA2243474A1 (fr) | 1997-07-24 |
| SK93198A3 (en) | 1999-01-11 |
| NO983333L (no) | 1998-09-18 |
| BR9707027A (pt) | 1999-07-20 |
| NO983333D0 (no) | 1998-07-17 |
| WO1997026244A1 (fr) | 1997-07-24 |
| CA2243474C (fr) | 2009-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59700372D1 (en) | Blockcopolymere | |
| ZA97364B (en) | Quinolin-2-(1h)-ones | |
| AU131131S (en) | Handleset | |
| ZA979603B (en) | Inductor | |
| GB2332674B (en) | Metallo-porphyrins | |
| AU131132S (en) | Handleset | |
| GB9625686D0 (en) | Tapered speeddeck | |
| AU131199S (en) | Handleset | |
| AU131198S (en) | Handleset | |
| HU9700455D0 (en) | Herbicidal combinations | |
| DE59610178D1 (en) | Rotationspumpe | |
| PL330823A1 (en) | Improved autoradiohraphy | |
| ZA973179B (en) | Herbicidal heterocycle-fused benzoylisothiazoles | |
| PL313849A1 (en) | Beta-aminoesters of o-hydrobenzylamides | |
| GB9602519D0 (en) | Cyclisation | |
| AU1593P (en) | Songlines Telopea speciosissima | |
| CA79582S (en) | Jerkin | |
| GB9810175D0 (en) | Phosphate-medicated cyclization | |
| TW325701U (en) | Improved | |
| GB9619291D0 (en) | Easyfeed pole rest | |
| GB9604122D0 (en) | Drawing aid | |
| GB9610660D0 (en) | Safetyt aid | |
| GB9602765D0 (en) | Publicans pipecleaning aid | |
| GB9606602D0 (en) | Structural member | |
| GB9620413D0 (en) | Structural member |